Latest Headlines

Latest Headlines

Microbix sues Novartis for patent infringement in Europe

Canada-based Microbix has slapped Novartis with a lawsuit in Europe, where it says the Swiss pharma giant has infringed its patent on Virusmax--a technology used for increasing virus yields in egg-based vaccine manufacturing.

Microbix blueprints $200M vaccine plant in China

The swine flu pandemic has been spurring some major new ventures in the vaccine industry. In one of the latest examples, Microbix Biosystems has teamed up with China's Hunan Biopharmaceutical in a